Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) has announced the availability of its first quarter fiscal year 2026 financial results on its Investor Relations website. The company will host a conference call and webcast with investors and analysts on August 7, 2025, at 8:00 a.m. ET to discuss the results.

The conference call requires pre-registration, and participants are recommended to join 10 minutes before the event. A replay of the conference call and webcast will be accessible for one year starting from August 7, 2025, at 11:00 a.m. ET.

Financial release accessible online

BOSTON, Aug. 7, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 7, 2025. The conference call and webcast can be accessed with the following information:

• Teleconference link:
  https://register-conf.media-server.com/register/BIb1de2bd7b8ba4267b7bc38da4e4008c7
• Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
• A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/wv7zkgdh

In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.

Direct link to 1Q FY26 Earnings Release:
https://haemonetics.gcs-web.com/static-files/078498e0-b75c-4cd4-94fb-93730b3b1c70

A replay of the conference call and webcast will be available for one year beginning on August 7, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com	david.trenk@haemonetics.com
Media Contact: Josh Gitelson, Sr. Director-Global Communications (781) 356-9776 josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website-302523396.html

SOURCE Haemonetics Corporation

FAQ

When is Haemonetics (HAE) Q1 FY2026 earnings call scheduled?

Haemonetics' Q1 FY2026 earnings call is scheduled for August 7, 2025, at 8:00 a.m. ET.

How can investors access Haemonetics' Q1 FY2026 earnings results?

Investors can access the earnings results through Haemonetics' Investor Relations website and join the conference call via the provided registration link.

How long will Haemonetics' Q1 FY2026 earnings call replay be available?

The earnings call replay will be available for one year beginning August 7, 2025, at 11:00 a.m. ET.

What is the registration process for Haemonetics' Q1 FY2026 earnings call?

Participants must register through the provided teleconference link to receive a dial-in number and personalized PIN. It's recommended to join 10 minutes before the event start.